| Journal of Nanobiotechnology | |
| Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis | |
| Liangcong Hu1  Ranyang Tao1  Bobin Mi1  Hang Xue1  Ze Lin1  Lang Chen1  Yiqiang Hu1  Xudong Xie1  Yuan Xiong1  Chenchen Yan1  Guohui Liu1  Adriana C. Panayi2  | |
| [1] Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology;Department of Plastic Surgery, Brigham and Women’s Hospital, Harvard Medical School; | |
| 关键词: Exosomes; Mesenchymal stem cells; Pioglitazone; Diabetic wound; Angiogenesis; | |
| DOI : 10.1186/s12951-021-00894-5 | |
| 来源: DOAJ | |
【 摘 要 】
Abstract Background Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising candidates for the treatment of diabetic wound healing. The present study aimed to investigate the effect of exosomes derived from MSCs pretreated with pioglitazone (PGZ-Exos) on diabetic wound healing. Results We isolated PGZ-Exos from the supernatants of pioglitazone-treated BMSCs and found that PGZ-Exos significantly promote the cell viability and proliferation of Human Umbilical Vein Vascular Endothelial Cells (HUVECs) injured by high glucose (HG). PGZ-Exos enhanced the biological functions of HUVECs, including migration, tube formation, wound repair and VEGF expression in vitro. In addition, PGZ-Exos promoted the protein expression of p-AKT, p-PI3K and p-eNOS and suppressed that of PTEN. LY294002 inhibited the biological function of HUVECs through inhibition of the PI3K/AKT/eNOS pathway. In vivo modeling in diabetic rat wounds showed that pioglitazone pretreatment enhanced the therapeutic efficacy of MSCs-derived exosomes and accelerated diabetic wound healing via enhanced angiogenesis. In addition, PGZ-Exos promoted collagen deposition, ECM remodeling and VEGF and CD31 expression, indicating adequate angiogenesis in diabetic wound healing. Conclusions PGZ-Exos accelerated diabetic wound healing by promoting the angiogenic function of HUVECs through activation of the PI3K/AKT/eNOS pathway. This offers a promising novel cell-free therapy for treating diabetic wound healing. Graphic abstract
【 授权许可】
Unknown